{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-025692","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2023-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.004567+00:00","generated_at":"2026-06-14T09:17:22.912000+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Outset Medical shareholders elect three Class III directors at 2023 annual meeting","bullets":["Jim Hinrichs elected with 31,328,771 votes for, 9,103,234 withheld.","Andrea L. Saia elected with 32,411,431 for, 8,020,574 withheld.","Catherine Szyman elected with 30,893,629 for, 9,538,376 withheld.","Advisory vote on 2022 executive compensation approved: 37,566,238 for, 2,837,679 against.","Ratification of KPMG as auditor for FY2023 approved: 42,975,493 for, 29,313 against."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-025692","json":"https://secwatch.observer/filing/0000950170-23-025692.json","markdown":"https://secwatch.observer/filing/0000950170-23-025692.md","text":"https://secwatch.observer/filing/0000950170-23-025692.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023025692/0000950170-23-025692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023025692/om-20230531.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T09:17:22.912000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d4008bc62daf481c94999b6bfb90306e970e1d0","claim":"Outset Medical, Inc. shareholders approved Election of Class III Directors at the 2023-05-31 meeting.","evidence_excerpt":"Proposal One: Election of Class III Directors Each of Jim Hinrichs, Andrea L. Saia and Catherine Szyman was elected to serve as a class III director to hold office until the Company’s 2026 annual meeting of stockholders and until the election and qualification of his or her successor. Votes were cast as follows: For Withheld Broker Non-Votes Jim Hinrichs 31,328,771 9,103,234 2,604,562 Andrea L. Saia 32,411,431 8,020,574 2,604,562 Catherine Szyman 30,893,629 9,538,376 2,604,562","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023025692/0000950170-23-025692-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"},{"claim_id":"cbcb6d2a7fc9d3b62a4b05614507fd21733f3a38","claim":"Outset Medical, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-31 meeting.","evidence_excerpt":"Proposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 by the following vote: For Against Abstain Broker Non-Votes 42,975,493 29,313 31,761 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023025692/0000950170-23-025692-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"},{"claim_id":"fe99fb845315ba00e0593e50e220f23a21ecb860","claim":"Outset Medical, Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2023-05-31 meeting.","evidence_excerpt":"Proposal Two: Advisory Vote on Named Executive Officer Compensation The Company’s stockholders approved, on a non-binding advisory basis, the 2022 compensation of the Company’s named executive officers as disclosed in its 2023 proxy statement by the following vote: For Against Abstain Broker Non-Votes 37,566,238 2,837,679 28,088 2,604,562","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000095017023025692/0000950170-23-025692-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-31"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}